3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
23
Fatigue
17
Neoplasms
9
Depression
6
Pain
5
Colorectal Neoplasms
4
Vomiting
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Nausea
3
Lung Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Anxiety Disorders
3
Sleep Wake Disorders
2
Sleep Initiation and Maintenance Disorders
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Oligodendroglioma
2
Obesity
2
Motor Activity
2
Meningioma
2
Medulloblastoma
2
Lymphedema
2
Leukemia
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Interventions
Fluorouracil
267
Oxaliplatin
266
Capecitabine
224
Leucovorin
209
Irinotecan
151
Radiotherapy
131
Bevacizumab
112
Cetuximab
81
Folfox protocol
48
Surgical Procedures, Operative
44
Radiation
41
Drug Therapy
41
Neoadjuvant Therapy
40
Chemoradiotherapy
33
Chemotherapy, Adjuvant
32
Panitumumab
27
XELOX
25
Magnetic Resonance Spectroscopy
22
Radiotherapy, Intensity-Modulated
21
Floxuridine
17
Biopsy
16
Nivolumab
15
Gemcitabine
15
Early Intervention, Educational
15
pembrolizumab
14
Laparoscopy
14
IFL protocol
14
Celecoxib
14
trifluridine tipiracil drug combination
13
Gene Expression Profiling
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Rectal Neoplasms
×
Yoga
×
Clear all
NCT01590147
2018-08-15
SIPS
Wake Forest University Health Sciences
Phase NA
Completed
15 enrolled
NCT02148406
2015-06-23
Pro-You
Vanderbilt-Ingram Cancer Center
Phase NA
Completed
3 enrolled